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Abstract
Objectives: The purpose of this review is to summarize the available evidence on the impact of non-
traumatic hip or knee disorders on health-related quality of life (HRQL), as measured with the Short Form
36 Health Survey (SF-36) or Short Form 12 Health Survey (SF-12), by comparing this with data from
reference populations. Methods: Studies were identiﬁed by an electronic search of the MEDLINE,
PsychInfo and Cinahl databases. Studies with the following features were included: study population
included patients with non-traumatic hip or knee disorders, the SF-36 or SF-12 was used as an outcome
measure and mean scores on these HRQL measures were presented. Using mean HRQL scores from the
selected studies and scores from reference populations, z-scores were computed. Pooled estimates were
computed for subgroups of studies with similar patients in similar settings. Results: A total of 40 studies met
the inclusion criteria. Patients with non-traumatic hip and knee disorders scored up to 2.5 standard
deviations (SDs) below reference population values, especially on the physical aspects of HRQL. Social and
mental aspects were up to 1 SD below reference population values, especially in patients in clinical settings.
Conclusions: The impact of non-traumatic hip or knee disorders on HRQL is substantial, especially on the
physical aspects of HRQL.
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Introduction
Hip and knee disorders are a frequent health
problem. Estimates of the prevalence of osteoar-
thritis (OA) depend on variations in deﬁnition, but
OA is thought to aﬀect more than 10–12% of the
population in the United States (US) [1]. The
12-months period prevalence of hip and knee dis-
orders among adults in the general population in
the Netherlands is estimated at 28% [2]. The
prevalence increases with age [2]. In the Nether-
lands, every year 10 per 1000 persons visit their
general practitioner (GP) with a new episode of
hip complaints and 31 per 1000 persons with a new
episode of knee complaints [3].
Hip and knee disorders have substantial conse-
quences for public health, because of their strong
impact on functional disability, health care costs,
sick leave and work disability [4–7]. The United
Nations, the World Health Organization (WHO),
governments, professional and patients’ organiza-
tions have therefore declared 2000–2010 the Bone
and Joint Decade, with the aim of determining the
burden of musculoskeletal diseases and improving
the health-related quality of life of people with
musculoskeletal conditions. Quantifying the health
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burden of disorders is critical to decisions involv-
ing the allocation of limited health care resources.
The burden of a disease relates not only to its
incidence and prevalence, but also to the impact of
the disease on the (health-related) quality of life
(HRQL) of the patients who suﬀer from it [8–10].
It is generally agreed upon that HRQL encom-
passes several diﬀerent dimensions including
physical, emotional and social functioning [11]. To
facilitate interpretation of HRQL data and to put
population scores into perspective, generic instru-
ments, such as the Short Form 36 Health Survey
(SF-36), are usually best suited: generic measures
facilitate comparisons of scores with those from a
reference population, and enable a comparison of
HRQL across diﬀerent disease groups.
Although HRQL in patients with hip and knee
disorders has been studied extensively using gen-
eric instruments, a systematic review about the
impact of hip and knee disorders, such as OA,
rheumatoid arthritis, bursitis, or non-speciﬁc hip
or knee pain, on HRQL is not yet available.
By pooling the results of separate studies, a
more precise estimate of the impact on HRQL can
be made. The purpose of this review was to sum-
marize the available evidence on the impact of
non-traumatic hip or knee disorders on HRQL. In
order to facilitate interpretation of the results and
to quantify the impact of hip and knee complaints
on HRQL, we wanted to compare patient scores
with reference data from the general population.
An extensive search of the literature showed that
the SF-36 and SF-12 were the only instruments for
which reliable country-speciﬁc reference data were
available. Therefore, we only included studies that
used the SF-36 or SF-12 to assess HRQL in our
systematic review.
Methods
Search strategy and study selection
The SF-36 [12] and SF-12 [13] are the most com-
monly used generic HRQL measures in patients
with hip or knee disorders. We conducted a sys-
tematic literature search to identify studies mea-
suring HRQL, using the SF-36 or SF-12, in
patients with non-traumatic hip or knee disorders.
Publications were selected from the following
databases: Medline (1966 until January 2003),
PsycINFO (1977 until January 2003) and Cinahl
(1982 until January 2003). No language restric-
tions were imposed.
The search terms used were (SF-36 or SF-12 or
SF-36 and SF-12 or ‘short form-36’ or ‘short form-
12’ or ‘Short Form 36 Health Survey’ or ‘Short
Form thirty-six health survey’ or ‘Short Form 12
Health Survey’ or ‘Short Form twelve health sur-
vey’) plus hip or knee (MESH or free text word).
The following criteria were used for inclusion of
studies in the review:
– The study population consists of patients with
non-traumatic hip or knee disorders.
– HRQL, deﬁned as physical, emotional or social
functioning, is measured using the SF-36 or SF-
12.
– The mean scores of patients with non-traumatic
hip or knee disorders on the SF-36 or SF-12 are
presented in the article.
The following criteria were used for exclusion of
studies from the review:
– The study population consists of patients after
surgery. Our aim was to quantify the impact of a
disorder and not the impact of a treatment.
– The study population consists of patients with
traumatic injuries.
– The study population contains fewer than 100
patients with non-traumatic hip or knee disor-
ders. This is an arbitrary cut-oﬀ point, but a
sample of at least 100 persons will provide more
reliable estimates of HRQL.
– The study population consists of patients par-
ticipating in a (randomized) clinical trial (RCT).
Due to strict selection criteria these patients are
often not representative for members of the
general population or patients encountered in
everyday primary or secondary care.
The ﬁrst author screened all titles, in order to ex-
clude articles that obviously did not meet the
selection criteria. Two independent reviewers (DW
and JW) scanned all remaining abstracts. During a
consensus meeting all abstracts that appeared to
meet the selection criteria were selected. The full
text of these articles was retrieved to select articles
that met all selection criteria. When multiple arti-
cles used the same data, we included the most re-
cent or most complete article. Finally, we
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handsearched the reference lists of all included
articles to ﬁnd additional eligible studies.
Data extraction
We extracted data from each article on the fol-
lowing study characteristics: mean age of the study
population, study size, country, setting, and case
deﬁnition (diagnosis, disease stage). Extracted
mean HRQL scores were entered into a custom-
made spreadsheet.
To examine the impact of hip and knee disor-
ders on HRQL we compared the scores on the
SF-36 or SF-12 with scores obtained from coun-
try-speciﬁc reference populations [14–23]. These
reference populations consist of a representative
sample from the general population and are usu-
ally used as normative data. If possible, age- and
sex-speciﬁc reference data were used. Details about
which reference populations were used are pro-
vided in the Results section.
Data analysis
We computed z-scores for each subscale of the SF-
36 or SF-12 by dividing the diﬀerence between the
mean HRQL score of the patient group and the
mean HRQL score of the reference population by
the standard deviation of the mean HRQL score of
the reference population. We computed z-scores
for the SF-36 Physical Component Summary
(PCS) and Mental Component Summary (MCS)
in the same way. The use of z-scores (‘norm-based
scoring’) has been recommended by the developers
of the SF-36 [24]. To compute z-scores, we used
country-speciﬁc normative data whenever avail-
able. Tables 1–3 show which data were used to
compute z-scores for each individual study.
No reference data from Switzerland were avail-
able. Instead, we used data from a French popu-
lation [15]. Since France is a neighbouring country
and a substantial number of inhabitants speak the
same language, we thought these reference data
were most suitable. When a study was conducted
in multiple countries, reference data were used
from the country that represented most patients.
Lingard et al. [25] performed a multicentre study
in the UK (six centres), the US (four centres) and
Australia (two centres). Most centres were in the
UK so reference data from an English population T
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were used [14]. Mahomed et al. [26] performed a
study in the US and Canada. As most patients
were from the US (60%), the American reference
data for the SF-36 [17] and the SF-12 [22] were
used.
Clark et al. [27] used the SF-36 PCS and MCS
to assess HRQL among male outpatients in the
US. As no sex-speciﬁc reference data are available
for SF-36 PCS and MCS scores, we used the
available reference data from a representative
sample of the American population [22]. Spanish
reference data for the SF-36 were sex-speciﬁc. For
the study by Escobar et al. [28] we decided to use
female reference data from Spain [23], because
most patients in this Spanish study were female
(TKA 56% and THA 71%).
Data synthesis and presentation
Results are presented separately for hip and knee
disorders (if possible) and for the following study
settings: general population, community-dwelling
elderly, primary care, clinic (hip or knee OA),
and in patients prior to total hip arthroplasty
(THA) or total knee arthroplasty (TKA). For
studies concerning similar patient populations
(with respect to diagnosis or mean age) and
similar settings, pooled estimates were computed
for separate dimensions of SF-36 or SF-12,
weighted by study size. Studies among commu-
nity-living elderly showed many diﬀerences
regarding characteristics of the patient population
(case deﬁnition, setting or age). Consequently, we
refrained from computing pooled z-scores for
these studies. We pooled two studies concerning
patients with knee or hip OA in clinical settings
(data from hip and knee patients were not pre-
sented separately in these studies) [29, 30], three
studies on patients with knee OA in clinical set-
tings [31–33], two studies on patients with knee or
hip OA, admitted or scheduled for TKA or THA
(data from hip and knee patients were also not
presented separately in these studies) [34, 35], 19
studies on patients with knee OA admitted
or scheduled for TKA [25, 26, 28, 33, 36–50]
and 23 studies on patients with hip OA admit-
ted or scheduled for THA [26, 28, 36, 39–46, 48–
59]. Deviations of more than 0.5 Standard
deviation (SD) from the reference population
(z-score < )0.5) were considered clinicallyTa
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important, based on recent guidelines for HRQL
research [60].
Results
Search
The results of our search strategy are presented in
Figure 1. The search strategy identiﬁed 323 ab-
stracts. After initial selection by the ﬁrst author
126 abstracts were excluded. Two independent
reviewers assessed the remaining 197 abstracts.
Another 135 abstracts were excluded. For the
remaining 62 abstracts the full text article was re-
trieved. Twenty-two of these 62 articles were ex-
cluded. Forty articles contained mean scores from
the SF-36 or SF-12, and were included in the re-
view. Handsearching the reference lists of these 40
articles did not result in the identiﬁcation addi-
tional relevant articles.
Characteristics of the study populations
The studies contained data about the HRQL of
patients with hip and knee disorders in ﬁve dif-
ferent settings. Of the 40 studies we included, one
study concerned patients in the general popula-
tion [61] (223 patients), three studies concerned
community living elderly [27, 62, 63] (in total
133,358 patients), one study concerned patients in
a primary care setting [64] (195 patients), ﬁve
studies concerned patients in clinical settings [29–
33] (in total 1407 patients) and thirty studies
concerned patients with OA admitted or sched-
uled for total arthroplasty (in total 5191 patients
admitted for TKA [25, 26, 28, 33, 36–50, 65] and
4236 patients admitted for THA [26, 28, 36, 39–
46, 48–59]) The characteristics of these studies are
described in Tables 1–3. One article [33] describes
HRQL of patients in clinical settings and of pa-
tients prior to TKA and therefore appears in
Tables 2 and 3.
The study in the general population concerned
patients with symptomatic knee OA. The studies
concerning community-living elderly included pa-
tients with knee pain, or knee or hip OA. The study
in primary care concerned patients presenting with
new episodes of hip pain. The studies in outpatient
clinics, rheumatology and rehabilitation clinics orT
a
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le
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tertiary hospitals, all included patients with hip or
knee OA or patients prior to TKA or THA.
HRQL in patients with hip or knee disorders
In Table 4 (pooled) z-scores are presented to show
the impact of hip and knee complaints on HRQL.
Table 4 demonstrates, for example, that elderly
patients with knee OA in the general population in
the US [63] scored on average 0.3 SDs below the
reference population on the SF-36 general health
subscale. Patients prior to THA (pooled estimate
of 23 studies) scored on average 2.5 SDs below the
reference population on the SF-36 physical func-
tioning subscale, and 2.0 SDs below the reference
population on the SF-36 role limitations in phys-
ical functioning subscale.
In studies using the PCS and MCS summary
scores, patients scored approximately 1.5–2.5 SDs
below the reference population for the SF-36 PCS
subscale and up to 0.5 SD below the reference
population for the SF-36 MCS subscale. Scores on
the SF-36 PCS and MCS scales were about 1 SD
lower in patients admitted for surgery than in
community living elderly.
Two studies used the SF-12. Carmona et al. [61]
performed a study in the general population in
Spain, and Hartley et al. [37] assessed HRQL in
patients scheduled for TKA in the UK. The results
show poorer scores for patients in the Spanish
general population, compared to patients sched-
uled for TKA in the UK.
In Figure 2, the data from Table 4 are presented
graphically. Figure 2 demonstrates that the proﬁle
for the diﬀerent subscales shows a similar pattern of
reduction in HRQL. Patients from all settings
scored approximately 1–2 SDs below the reference
population for three subscales of the SF-36: physi-
cal functioning, role limitations in physical func-
tioning, and bodily pain. The scores on mental
health in patients in the general population, primary
care or among community-living elderlywere rather
323 abstracts
initial selection by first author 
197 abstracts
two independent reviewers 
126 abstract excluded, reasons:
51 also found in other database
30 not about hip/knee complaints
31 about traumatic injury 
10 SF-36/SF-12 was not used
4 RCT
135 abstract excluded, reasons:
8 not about hip/knee complaints
6 about traumatic injury 
11 SF-36/SF-12 was not used
20 RCT
37 after surgery 
53 <100 patients
22 articles excluded, reasons:
1 about traumatic injury 
1
5 
13 no mean scores presented 
2 same results in more recent article
40 articles included in the revew 
62 full text 
after surgery 
<100 patients
Figure 1. Study selection.
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similar to scores from reference populations. Scores
on mental health were worse in patients in clinical
settings. Clinical outpatients and patients admitted
for surgery (TKA or THA) scored up to1 SD below
the reference population for mental health.
Discussion
The results of this systematic review of 40 obser-
vational studies measuring HRQL in patients with
non-traumatic hip or knee disorders show that
these disorders have a substantial impact on
HRQL. According to previous studies, the
threshold for clinically important changes in
health-related quality of life appears to be half a
SD [60]. The scores on subscales with physical
components were especially low: up to 2 SDs be-
low reference values. Scores on subscales with
mental and social components were only low for
patients seen in clinical settings and those admitted
for THA or TKA (up to 1 SD below reference
values). These results indicate that patients from
all settings were markedly impaired in their phys-
ical functioning, and that patients in clinical set-
tings (who may have more severe hip or knee
disorders) generally have a poor HRQL.
Remarkably, the proﬁle among the various sub-
scales is about the same among all patient groups.
To put the results of our review into perspective,
we compared the scores from the patient groups
included in our review with those obtained from
patients with other disorders, retrieved from the
literature. This comparison shows that patients
with hip or knee disorders have poorer scores on
several dimensions of HRQL than patients with
heart disease or cancer [66]. Patients with heart
disease or cancer score up to 1.2 SD below reference
values on physical subscales [67]. Although some of
the HRQL eﬀects seen in OA patients may have
been caused by comorbidities, such as hypertension
or cardiovascular disease [68], that aﬀect persons
Figure 2. z-Scores for each subscale of the SF-36, the two summary scales of the SF-36, and the SF-12 subscales in diﬀerent patient
populations. PF: physical functioning, RP: role limitations in physical functioning, BP: bodily pain, GH: general health, VT: vitality,
SF: social functioning, RE: role limitations in emotional functioning, MH: mental health, PCS: physical component score, MCS:
mental component score, SF-12 ph: SF-12 physical subscale, SF-12 Ps: SF-12 psychological subscale
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with OA, this comparison suggests that hip or knee
disorders can have a substantial eﬀect on HRQL.
The results of this review show that patients
with hip or knee disorders generally have high
pain scores, which limits physical and social
functioning. This draws attention to the impor-
tance of pain management and coping with pain
in these patient groups. Interventions should be
developed and evaluated that are directed
towards reduction of pain, improvement of
functional capacity, and HRQL of patients with
hip or knee problems.
The population in western countries is aging,
and an increasing number of people are suﬀering
from hip or knee complaints. Most of these pa-
tients are encountered and cared for in primary
care. However, only one study measured HRQL in
patients with hip or knee disorders in a primary
care setting. This study [64] concerned an older
population, which may limit the possibilities for
generalizing these results to other primary care
populations. More research should be aimed at
assessing and improving HRQL in patients with
hip or knee problems in primary care.
Although the SF-36 is widely available and
validated in many languages, for most reference
populations, age- and sex-speciﬁc data are not
available, and for one study included in this review
data from a country-speciﬁc reference population
were not available at all [30]. Furthermore, one
study was performed in male patients and no sex-
speciﬁc reference data were available [27]. Another
study was performed in both male and female
patients, but only sex-speciﬁc reference data were
available [28]. These factors mean that our z-scores
may have been somewhat biased because we could
not use an appropriate reference population.
Women generally score poorer on HRQL ques-
tionnaires than men. Thus, in studies for which we
had to use female reference data, we may have
slightly underestimated z-scores. In addition, the
mean age of the reference population was in some
studies lower than the mean age of the study
population. This means that the burden of hip and
knee disorders on the physical subscales may have
been slightly overestimated. In the US reference
population, the scores on the physical subscales
for people aged 65–74 years were about 0.2–0.5
SD lower than the mean scores of the general
population [17]. This may give an indication of the
amount of overestimation in this study due to
younger age of a reference population.
To our knowledge guidelines for pooling z-
scores are not yet available. We decided to com-
pute pooled z-scores weighted by study size. The
inverse of the variance of an estimate is more often
used as a weighting factor in meta-analysis.
However, in our review the variance is part of the
outcome of each study (the z-score). Using the
inverse of the variance as a weighting factor would
mean that studies that show a wide range in
HRQL scores (which may accurately reﬂect
HRQL in the assessed population) would receive
less weight in the pooled estimate. This would have
aﬀected the results of our review somewhat.
We only selected studies using the SF-36 or SF-
12 for our review. Other generic and disease-spe-
ciﬁc measures are available and have been used in
studies concerning patients with non-traumatic hip
and knee complaints. For these measures often no
information is available as to what scores repre-
sent important limitations in health, and data from
reference populations are generally not available,
which hampers the interpretation of absolute
scores. More attention should be paid to the
meaning of absolute scores of health status ques-
tionnaires, and age- and sex-speciﬁc reference data
of the general population should be provided.
The study in the general population in Spain is
said to consist of patients with knee OA, obtained
from a representative sample of the Spanish general
population [61]. Unexpectedly, these results showed
a lower z-score for these patients than for patients
admitted for TKA, which raises doubt about the
representativeness of these patients with knee OA.
In conclusion, this is the ﬁrst review to quantify
the impact of non-traumatic hip or knee disorders
on HRQL. This impact turns out to be substantial,
especially the impact on physical aspects of
HRQL. The results of this review support the
eﬀort of the organizers of the Bone and Joint
Decade [10] to determine the burden of musculo-
skeletal diseases and underscore their statement
that the HRQL of people with musculoskeletal
conditions should be improved.
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